id: NEW:psychedelic_therapy_physiological_effects_to_hypertension_diagnosis
name: Psychedelic Therapy Physiological Effects â†’ Hypertension Diagnosis
from_node:
  node_id: NEW:psychedelic_therapy_physiological_effects
  node_name: Psychedelic Therapy Physiological Effects
to_node:
  node_id: hypertension_diagnosis
  node_name: Hypertension Diagnosis
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Psychedelic compounds administered during therapy session'
- 'Step 2: Serotonergic activity of psychedelics causes transient cardiovascular effects'
- 'Step 3: Blood pressure increases transiently during the psychedelic experience'
- 'Step 4: Requires medical monitoring and may be contraindicated in patients with cardiovascular conditions'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Dakota J. Sicignano et al. 2023. "The impact of psychedelics on patients with alcohol
    use disorder: a systematic review with meta-analysis." https://doi.org/10.1080/03007995.2023.2296968'
  supporting_citations:
  - Trial reporting transient blood pressure increases (specific citation requires full-text access)
  doi: 10.1080/03007995.2023.2296968
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: One trial reported transient increases in blood pressure during psychedelic therapy, a known
  pharmacological effect requiring further exploration to determine the balance of benefits to harms,
  particularly for patients with cardiovascular comorbidities.
moderators:
- name: baseline_cardiovascular_status
  direction: strengthens
  strength: moderate
  description: Patients with pre-existing hypertension or cardiovascular disease may experience greater
    risk from transient blood pressure elevations
structural_competency:
  equity_implications: Cardiovascular safety monitoring requirements create structural barriers to psychedelic
    therapy access in settings without adequate medical infrastructure. This may limit access for populations
    in healthcare deserts or those without established primary care relationships for pre-treatment cardiovascular
    screening.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.297368'
  extraction_confidence: low
  prompt_version: 2.1-canonical-validated
